Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis
IntroductionPeripheral blood inflammatory markers (PBIMs) are widely used for prognostication of several malignancies, including gynecologic cancers. However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pre…